Revenue segments as reported by the company.

U.S. Healthcare Solutions

International Healthcare Solutions

Pharmaceutical Distribution Services

Other

Intersegment eliminations

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Distribution, selling, and administrative

Depreciation and amortization

Employee severance, litigation, and other

Goodwill impairment

Impairment of assets

Acquisition, integration, and restructuring expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

AmerisourceBergen

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health, and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded by in Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment is involved in the offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a wide variety of healthcare providers. The International Healthcare Solutions segment includes businesses that focus on international pharmaceutical wholesale and related service operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today hosted an investor day event in New York City. Steven H. Collis, Chairman, President & Chief Executive Officer; James F. Cleary, EVP & Chief Financial Officer; Bob Mauch, EVP & Group President; and Susan Lorenz-Fisher, SVP, Corporate Responsibility & Sustainability, discussed the company's purpose, strategic imperatives, ESG commitments, and long-term financial growth outlook. “As a global health

AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day

AmerisourceBergen Corp. ABC, -1.32% said Wednesday that it set a new $1 billion stock repurchase program. That represents 3.1% of the pharmaceutical and health care products company's market capitalization of $32.42 billion at Tuesday's stock closing price.

AmerisourceBergen sets $1 billion stock buyback program

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reiterated its previously provided guidance for fiscal year 2022 and announced that its Board of Directors has authorized a new share repurchase program. The investor day will include presentations by company leaders focusing on AmerisourceBergen's purpose, strategic imperatives, ESG commitments, and long-term financial growth outlook. “We are excited to showcase how AmerisourceBergen is building on our leadersh

AmerisourceBergen Investor Day to Highlight Strategic Imperatives and Provide Long-Term Financial Outlook

AmerisourceBergen is a leading global drug distributor with a strong focus on operational excellence. The company has recently resolved the majority of its legal troubles related to the Opioid crisis, and is now free to continue growing its business.

AmerisourceBergen: A Healthy, Wealthy Stock You Can Count On

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen (AB), a global healthcare company and leader in specialty pharmaceutical services and distribution for more than 20 years, today launched Clinical Trial Navigator, a solution suite that assists with biopharmaceutical clinical trial recruitment specifically within community-based specialty practices. Leveraging AB's robust research community AdvanceIQ Network, Clinical Trial Navigator unites oncology practices and their patients with trials t

AmerisourceBergen Launches Clinical Trial Navigator to Bolster Equitable and Accessible Community-Based Research Opportunities Nationwide

Shares of AmerisourceBergen Corp. suffered the biggest selloff in more than two years on Thursday, after the drug products and distribution company's largest investor sold off a chunk of its stake.

AmerisourceBergen's stock tanks after largest investor sells $900 million worth of shares

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it is resuming share repurchases with excess free cash flow in accordance with the company's disciplined approach to capital allocation. The company remains fully committed to maintaining its investment grade credit ratings, which involves paying down $2 billion in debt within two years of the June 2021 acquisition of Alliance Healthcare. As noted during its most recent earnings call, the company

AmerisourceBergen Provides Update on Capital Deployment

Walgreens Boots Alliance Inc (NASDAQ: WBA) has sold 6.0 million shares of AmerisourceBergen Corp (NYSE: ABC) at $150 per share. After the sale, Walgreens Boots Alliance's ownership of AmerisourceBergen's common stock decreased from approximately 28.1% to 25.2%.

What's Going On With AmerisourceBergen Shares Today

Walgreens

DEERFIELD, Ill.--(BUSINESS WIRE)--WBA announced that it has sold 6.0 million shares of AmerisourceBergen Corporation common stock pursuant to Rule 144 at a price of $150 per share.

Walgreens Boots Alliance Sells Six Million Shares of AmerisourceBergen Corporation

On Thursday, Amerisourcebergen got an upgrade for its IBD SmartSelect Composite Rating from 94 to 96. The post Composite Rating For Amerisourcebergen Jumps To 96 appeared first on Investor's Business Daily.

Composite Rating For Amerisourcebergen Jumps To 96

AmerisourceBergen's (ABC) fiscal second-quarter results benefit from segmental growth.

AmerisourceBergen (ABC) Q2 Earnings & Revenues Top Estimates

AmerisourceBergen Corporation (NYSE:ABC ) Q2 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Bennett Murphy - Senior Vice President-Investor Relations Steve Collis - Chairman, President & Chief Executive Officer Jim Cleary - Executive Vice President & Chief Financial Officer Conference Call Participants Elizabeth Anderson - Evercore Lisa Gill - JPMorgan Charles Rhyee - Cowen Steven Valiquette - Barclays Eric Percher - Nephron Research Eric Coldwell - Baird George Hill - Deutsche Bank Michael Cherny - Bank of America Operator Good morning or good afternoon all. Welcome to the AmerisourceBergen Corporation Fiscal 2022 Second Quarter Earnings Call.

AmerisourceBergen Corporation (ABC) CEO Steve Collis on Q2 2022 Results - Earnings Call Transcript

AmerisourceBergen (ABC) delivered earnings and revenue surprises of 7.69% and 0.89%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

AmerisourceBergen (ABC) Tops Q2 Earnings and Revenue Estimates

AmerisourceBergen Corp. ABC, +1.20% reported first-quarter profit and revenue that rose above expectations, amid strength in international healthcare business, and raised its full-year outlook. The health care services company's stock was still inactive in premarket trading.

AmerisourceBergen beats earnings expectations, and lifts full-year guidance

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2022 second quarter ended March 31, 2022, revenue increased 17.4 percent year-over-year to $57.7 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.59 for the March quarter of fiscal 2022 compared to $2.10 in the prior year quarter. Adjusted diluted EPS, which is a non-GAAP measure that excludes items described b

AmerisourceBergen Reports Fiscal 2022 Second Quarter Results

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Global healthcare company AmerisourceBergen (AB) convened leaders and innovators across the biopharmaceutical industry on Monday for its ThinkLive Commercialization summit, an annual event centered on strategies and solutions that help companies maximize success at every stage of the product lifecycle. During the summit in Las Vegas, leaders discussed the challenges and considerations companies face when bringing a product to market, and how AB is strengtheni

AmerisourceBergen & Biopharmaceutical Companies Discuss Strategies to Advance Pharmaceutical Innovation and Access at ThinkLive Commercialization Conference

Cardinal Health

McKesson

CONSHOHOCKEN, Pa. & DUBLIN, Ohio & IRVING, Texas--(BUSINESS WIRE)--AmerisourceBergen (NYSE: ABC), Cardinal Health (NYSE: CAH) and McKesson (NYSE: MCK) announced today that they have reached an agreement with the Washington Attorney General, under which the distributors will pay up to $518 million to the State of Washington and its participating subdivisions to resolve opioid-related claims. This amount is consistent with Washington's allocation under the previously announced comprehensive agree

Distributors Agree to Opioid Settlement With Washington State

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen (AB), a global healthcare company, today announces a program designed to help hospitals and health systems launch or optimize home infusion service lines. As site-of-care strategies grow in importance, health systems with strong outpatient infusion center performance are increasingly leveraging home infusion to prevent potential care gaps, particularly as therapeutic advancements continue to broaden the range of treatments available for the

AmerisourceBergen Launches Home Infusion Solution for Health Systems Nationwide

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Global healthcare company AmerisourceBergen (AB) announced today its partnership with Chronicled, the administrator of the MediLedger Network, to leverage a new blockchain-powered solution designed to enhance pharmaceutical chargeback accuracy and significantly reduce chargeback rejections. The blockchain solution will allow AB to streamline and optimize the complex process of pharmaceutical chargebacks while creating greater connectivity for its suppliers an

AmerisourceBergen Partners with Chronicled to Optimize Pharmaceutical Chargeback Accuracy Using Blockchain-Powered Technology

AmerisourceBergen's (ABC) new corporate venture capital fund to help emerging healthcare startup companies change healthcare for people and animals globally.

AmerisourceBergen's (ABC) Venture Capital Fund to Aid Healthcare

AbbVie

Archer-Daniels-Midland Company

Amphastar Pharma

CF Industries Holdings

Chevron

Hershey

Kroger

The start of 2022 saw a decline in the stock market. For seasoned investors, this was not unexpected, as corrections in the market are commonplace from January through to March.

10 Stocks That Have Moved Over 20% Since The Indices Lost Over 12%!

Investors are optimistic about AmerisourceBergen's (ABC) strength in its World Courier business.

AmerisourceBergen (ABC) Hits 52-Week High: What's Aiding It?

FedEx

Kinder Morgan

We've put together the following list of 3 dividend growth stocks to help you fight inflation. Here are a few reasons why these companies stand out as great long-term buys.

3 Dividend Growth Stocks to Help You Fight Inflation

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Good Neighbor Pharmacy, AmerisourceBergen's nationwide network of independent community pharmacies, today announced that it has exceeded 5 million COVID-19 vaccine doses allocated to independent pharmacies across the U.S. This allocation effort is a part of the Federal Retail Pharmacy Program for COVID-19 Vaccination, a collaboration between the Federal Government, U.S. states and territories, and 21 national pharmacy partners, which includes Good Neighbor Ph

AmerisourceBergen & Good Neighbor Pharmacy Surpass 5 Million Vaccine Doses Allocated through its Federal Retail Pharmacy Program for COVID-19 Vaccination

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2022 on Wednesday, May 4, 2022, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 4, 2022. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F. Cleary, Executive Vic

News for AmerisourceBergen Stock (ABC)